Evolving Roles of Fluorodeoxyglucose and Sodium Fluoride in Assessment of Multiple Myeloma Patients: Introducing a Novel Method of PET Quantification to Overcome Shortcomings of the Existing Approaches.
PET Clin
; 14(3): 341-352, 2019 Jul.
Article
em En
| MEDLINE
| ID: mdl-31084774
ABSTRACT
PET with fluorodeoxyglucose and sodium fluoride (NaF) radiotracers has shown a great promise in assessing patients with multiple myeloma (MM). However, the standardization of PET/computed tomography scans interpretation in patients with myeloma in clinical practice is still debatable. This article reviews available data regarding the use of fluorodeoxyglucose and NaF PET in patients with MM. Introduced is a novel method of PET quantification as applied to patients with MM. A new concept for PET-based evaluation of patients with MM is also discussed dual time point imaging. Finally, the role of NaF in assessment of cardiovascular complications of MM is described.
Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Fluoreto de Sódio
/
Compostos Radiofarmacêuticos
/
Fluordesoxiglucose F18
/
Tomografia por Emissão de Pósitrons combinada à Tomografia Computadorizada
/
Mieloma Múltiplo
Limite:
Humans
Idioma:
En
Ano de publicação:
2019
Tipo de documento:
Article